Minnesota Oncology

Head and Neck Cancer News

USPSTF Issues Final Recommendation on Oral Cancer Screening (December 18, 2013)

The U.S. Preventive Services Task Force (USPSTF) has released its final recommendation regarding screening for oral cancer. The task force issued an “I” statement, which means there is not enough evidence to make a definitive recommendation for or... Continue Reading

Swallowing Exercises and Oral Nutrition Are Critical During Treatment for Oral Cancer (October 7, 2013)

Patients with oral cancers who receive oral nutrition and practice swallowing exercises throughout their treatment are able to maintain a significantly better long-term diet, according to the results of a study published in JAMA Otolaryngology Head and... Continue Reading

End-of-Life Care Remains Aggressive, Despite Patient Wishes (September 16, 2013)

Although most patients with advanced cancer prefer hospice or palliative care that minimizes symptoms, many continue to receive aggressive treatment during their final weeks and months of life. In fact, elderly patients with advanced cancer often receive... Continue Reading

Adding Vectibix to Cisplatin/Fluorouracil Improves Progression-Free Survival in Recurrent or Metastatic Head and Neck Cancer (August 2, 2013)

The addition of Vectibix® (panitumumab) to cisplatin/fluorouracil as first-line treatment improves progression-free survival in patients with recurrent or metastatic head and neck cancer, according to the results of a study published in The Lancet Oncology. Head... Continue Reading

Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)

People who follow the diet and lifestyle recommendations laid out by the World Cancer Research Fund (WCRF) and the American Institute for Cancer Research (AICR) have a 34 percent reduced risk of dying from several diseases and specifically, a 20 percent... Continue Reading

Cancer Deaths on the Decline (February 11, 2013)

Overall cancer death rates continue to decline in both men and women and across major ethnic and racial groups, according to the annual Status of Cancer report published in the Journal of the National Cancer Institute. What’s more—cancer incidence... Continue Reading

Doxepin Reduces Mouth Pain from Radiation for Head and Neck Cancer (November 14, 2012)

The tricyclic antidepressant doxepin reduces oral mucositis in patients who receive radiation for head and neck cancer, according to the results of a study presented at the 54th annual meeting of the American Society for Radiation Oncology in Boston,... Continue Reading

Approximately 16% of Worldwide Cancers Caused By Preventable Infections (May 17, 2012)

Two million cancer cases each year—or roughly 16 percent of cancers worldwide—are the result of preventable and treatable infections such as human papillomavirus (HPV) and Hepatitis C (HCV), according to the results of a study published in The Lancet... Continue Reading

Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)

A combined analysis of 51 randomized trials found that daily aspirin use reduces the risk of new cancer diagnoses as well as the risk of cancer death. These results were published in The Lancet. A growing body of evidence suggests that aspirin may reduce... Continue Reading

Combined Treatment Provides Benefit for Nasopharyngeal Cancer (February 22, 2012)

Among patients with Stage II nasopharyngeal cancer (a type of head and neck cancer), adding chemotherapy to radiation therapy resulted in better survival than radiation therapy alone. These results were published in the Journal of the National Cancer... Continue Reading

Latest Head and Neck Cancer News By Stage


General Head and Neck Cancer

USPSTF Issues Final Recommendation on Oral Cancer Screening (December 18, 2013)

The U.S. Preventive Services Task Force (USPSTF) has released its final recommendation regarding screening for oral cancer. The task force issued an “I” statement, which means there is not enough evidence to make a definitive recommendation for or... Continue Reading

Swallowing Exercises and Oral Nutrition Are Critical During Treatment for Oral Cancer (October 7, 2013)

Patients with oral cancers who receive oral nutrition and practice swallowing exercises throughout their treatment are able to maintain a significantly better long-term diet, according to the results of a study published in JAMA Otolaryngology Head and... Continue Reading

Adding Vectibix to Cisplatin/Fluorouracil Improves Progression-Free Survival in Recurrent or Metastatic Head and Neck Cancer (August 2, 2013)

The addition of Vectibix® (panitumumab) to cisplatin/fluorouracil as first-line treatment improves progression-free survival in patients with recurrent or metastatic head and neck cancer, according to the results of a study published in The Lancet Oncology. Head... Continue Reading

Doxepin Reduces Mouth Pain from Radiation for Head and Neck Cancer (November 14, 2012)

The tricyclic antidepressant doxepin reduces oral mucositis in patients who receive radiation for head and neck cancer, according to the results of a study presented at the 54th annual meeting of the American Society for Radiation Oncology in Boston,... Continue Reading

Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)

A combined analysis of 51 randomized trials found that daily aspirin use reduces the risk of new cancer diagnoses as well as the risk of cancer death. These results were published in The Lancet. A growing body of evidence suggests that aspirin may reduce... Continue Reading

More General Head and Neck Cancer